Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies

Shanshan Wan; Ende Zhao; Daniel Freeman; Daniel Weissinger; Benjamin A Krantz; Gregor Werba; Lauren G Khanna; Despina Siolas; Paul E Oberstein; Pratip K Chattopadhyay; Diane M Simeone; Theodore H Welling

doi:10.3389/fimmu.2023.1177713

Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies

Front Immunol. 2023 Mar 23:14:1177713. doi: 10.3389/fimmu.2023.1177713. eCollection 2023.

Authors

Shanshan Wan¹, Ende Zhao^{1

2}, Daniel Freeman³, Daniel Weissinger², Benjamin A Krantz^{2

4}, Gregor Werba², Lauren G Khanna⁴, Despina Siolas^{2

4}, Paul E Oberstein^{2

4}, Pratip K Chattopadhyay^{2

3

5}, Diane M Simeone^{1

2

3}, Theodore H Welling^{1

2}

Affiliations

¹ Department of Surgery, NYU Langone Health, New York, NY, United States.
² Perlmutter Cancer Center, NYU Langone Health, New York, NY, United States.
³ Pathology, NYU Langone Health, New York, NY, United States.
⁴ Internal Medicine, NYU Langone Health, New York, NY, United States.
⁵ Talon Biomarkers, Mendham, NJ, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1067352.].

Keywords: T cell biology; checkpoint inhibitors; cholangiocarcinoma; hepatocellular carcinoma; immune oncology; pancreatic adenocarcinoma; tumor immunity.

Publication types

Published Erratum